These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 9209457

  • 1. The anti-tumor effects of IL-12 involve enhanced IFN-gamma production by anti-tumor T cells, their accumulation to tumor sites and in situ IFN-gamma production.
    Fujiwara H, Hamaoka T.
    Leukemia; 1997 Apr; 11 Suppl 3():570-1. PubMed ID: 9209457
    [Abstract] [Full Text] [Related]

  • 2. IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways.
    Yu WG, Ogawa M, Mu J, Umehara K, Tsujimura T, Fujiwara H, Hamaoka T.
    J Leukoc Biol; 1997 Oct; 62(4):450-7. PubMed ID: 9335314
    [Abstract] [Full Text] [Related]

  • 3. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 4. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
    Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T.
    Int Immunol; 1995 Jul 01; 7(7):1135-45. PubMed ID: 8527411
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T, Seki S, Takeda K, Narita J, Ebe Y, Naito M, Hiraide H, Abo T.
    Cell Immunol; 1999 May 01; 193(2):219-25. PubMed ID: 10222065
    [Abstract] [Full Text] [Related]

  • 6. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.
    Yu WG, Yamamoto N, Takenaka H, Mu J, Tai XG, Zou JP, Ogawa M, Tsutsui T, Wijesuriya R, Yoshida R, Herrmann S, Fujiwara H, Hamaoka T.
    Int Immunol; 1996 Jun 01; 8(6):855-65. PubMed ID: 8671675
    [Abstract] [Full Text] [Related]

  • 7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 01; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 8. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N, Zou JP, Li XF, Takenaka H, Noda S, Fujii T, Ono S, Kobayashi Y, Mukaida N, Matsushima K.
    J Immunol; 1995 Mar 01; 154(5):2281-90. PubMed ID: 7868900
    [Abstract] [Full Text] [Related]

  • 9. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, Kaneda K, Fujii T, Senoh H, Fujiwara H.
    Hepatology; 1996 Jun 01; 23(6):1608-15. PubMed ID: 8675184
    [Abstract] [Full Text] [Related]

  • 10. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y, Yu WG, Mukai T, Gao P, Yamaguchi N, Murai M, Matsushima K, Obika S, Imanishi T, Higashibata Y, Nomura S, Kitamura Y, Fujiwara H, Hamaoka T.
    Cancer Res; 2002 Jul 01; 62(13):3751-8. PubMed ID: 12097285
    [Abstract] [Full Text] [Related]

  • 11. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma.
    Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT, Sher A, Seder RA.
    J Immunol; 1995 Jul 15; 155(2):785-95. PubMed ID: 7608555
    [Abstract] [Full Text] [Related]

  • 12. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
    Taylor LS, Cox GW, Melillo G, Bosco MC, Espinoza-Delgado I.
    Cancer Res; 1997 Jun 15; 57(12):2468-73. PubMed ID: 9192827
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP.
    Cancer Res; 2002 Aug 01; 62(15):4390-7. PubMed ID: 12154045
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 01; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 15. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S, Freedman RS, Rodriguez-Villanueva J, Platsoucas CD.
    Lymphokine Cytokine Res; 1993 Dec 01; 12(6):429-37. PubMed ID: 8123759
    [Abstract] [Full Text] [Related]

  • 16. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.
    Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM, Hamilton TA.
    J Immunol; 1996 Jan 15; 156(2):693-9. PubMed ID: 8543822
    [Abstract] [Full Text] [Related]

  • 17. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Jan 15; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 18. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
    Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ.
    J Immunol; 1994 Aug 15; 153(4):1697-706. PubMed ID: 7913943
    [Abstract] [Full Text] [Related]

  • 19. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
    Sherwood ER, Varma TK, Fram RY, Lin CY, Koutrouvelis AP, Toliver-Kinsky TE.
    Clin Sci (Lond); 2001 Dec 15; 101(6):541-50. PubMed ID: 11724637
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase.
    Zhu YN, Yang YF, Ono S, Zhong XG, Feng YH, Ren YX, Ni J, Fu YF, Tang W, Zuo JP.
    Int Immunol; 2006 Jun 15; 18(6):981-90. PubMed ID: 16636012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.